C.L. Leese
-
- Bone health and treatments 1
-
- Acute Myeloid Leukemia Research 1
-
- Enzyme function and inhibition 2
- Glycosylation and Glycoproteins Research 1
- Cancer therapeutics and mechanisms 1
-
- Bioactive Compounds and Antitumor Agents 1
-
- Neuroendocrine Tumor Research Advances 1
-
- Estrogen and related hormone effects 1
- Co-authors
- C TurbervilleU. StevensR BettelheimE.W. JohnsD. J. R. LaurenceD. A. DARCYPeter B. AlexanderP. K. Bondy
- Partner nations
- United Kingdom
In The Last Decade
C.L. Leese
11 papers receiving 362 citations
Peers
Comparison fields: 5 of 71
- Oncology 218
- Radiology, Nuclear Medicine and Imaging 136
- Hematology 34
- Pulmonary and Respiratory Medicine 77
- Molecular Biology 128
Countries citing papers authored by C.L. Leese
This map shows the geographic impact of C.L. Leese's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C.L. Leese with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C.L. Leese more than expected).
Fields of papers citing papers by C.L. Leese
This network shows the impact of papers produced by C.L. Leese. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C.L. Leese. The network helps show where C.L. Leese may publish in the future.
Co-authorship network
The 25 scholars most cited alongside C.L. Leese, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 7 | |
| 2 | 1976 | 45 | |
| 3 | 1976 | 35 | |
| 4 | 1975 | 39 | |
| 5 | 1975 | 6 | |
| 6 | 1972 | 269 | |
| 7 | 1972 | 1 | |
| 8 | 1970 | 4 | |
| 9 | 1965 | 17 | |
| 10 | 1964 | 11 | |
| 11 | 1963 | 3 |
About C.L. Leese
C.L. Leese is a scholar working on Toxicology, Clinical Biochemistry, Biochemistry, Oncology and Hematology, having authored 11 papers that have together received 437 indexed citations. Recurring topics across this work include Enzyme function and inhibition (2 papers), Glycosylation and Glycoproteins Research (1 paper), Bioactive Compounds and Antitumor Agents (1 paper), Cancer therapeutics and mechanisms (1 paper), Acute Myeloid Leukemia Research (1 paper), Bone health and treatments (1 paper), Neuroendocrine Tumor Research Advances (1 paper) and Estrogen and related hormone effects (1 paper). The work is most often cited by research in Oncology (218 citations), Radiology, Nuclear Medicine and Imaging (136 citations), Hematology (34 citations), Pulmonary and Respiratory Medicine (77 citations) and Molecular Biology (128 citations). C.L. Leese has collaborated with scholars based in United Kingdom. Frequent co-authors include C Turberville, U. Stevens, R Bettelheim, E.W. Johns, D. J. R. Laurence, D. A. DARCY, Peter B. Alexander, P. K. Bondy, T.J. Powles and John F. Smyth. Their work appears in journals such as Biochemical Pharmacology, Cancer, The Journal of School Nursing, Journal of the Chemical Society (Resumed) and European Journal of Cancer (1965).
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.